Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles

npj Science of Food

Volumn 1, Issue 1, 2017, Pages

  McClements, David Julian ^a   Xiao, Hang ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136620246     PISSN: None     EISSN: 23968370     Source Type: Journal    
DOI: 10.1038/S41538-017-0005-1     Document Type: Article

References (137)

1. Chaudhry, Q. et al. Applications and implications of nanotechnologies for the food sector. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk Assess. 25, 241–258 (2008).
2. Sozer, N. & Kokini, J. L. Nanotechnology and its applications in the food sector. Trends Biotechnol. 27, 82–89 (2009).
3. Livney, Y. D. Milk proteins as vehicles for bioactives. Curr. Opin. Colloid Interface Sci. 15, 73–83 (2010).
4. Holt, C., de Kruif, C. G., Tuinier, R. & Timmins, P. A. Substructure of bovine casein micelles by small-angle X-ray and neutron scattering. Colloid Surf. A 213, 275–284 (2003).
5. Iwanaga, D. et al. Extraction and characterization of oil bodies from soy beans: A natural source of pre-emulsified soybean oil. J. Agric. Food Chem. 55, 8711–8716 (2007).
6. Bellmann, S. et al. Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials. Nanomed. Nanobiotech. 7, 609–622 (2015).
7. Szakal, C. et al. Measurement of nanomaterials in foods: integrative considera-tion of challenges and future prospects. ACS Nano 8, 3128–3135 (2014).
8. Yada, R. Y. et al. Engineered nanoscale food ingredients: evaluation of current knowledge on material characteristics relevant to uptake from the gastrointestinal tract. Comp. Rev. Food Sci. Food Saf. 13, 730–744 (2014).
9. Gupta, A., Eral, H. B., Hatton, T. A. & Doyle, P. S. Nanoemulsions: formation, properties and applications. Soft Matter 12, 2826–2841 (2016).
10. Fellows, P. J. Food Processing Technology 4th edn (Woodhead Publishing, 2017).
11. Buzea, C. Pacheco, II & Robbie, K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2, MR17–MR71 (2007).
12. Frohlich, E. E. & Frohlich, E. Cytotoxicity of nanoparticles contained in food on intestinal cells and the gut microbiota. Int. J. Mol. Sci. 17, 1–22 (2016).
13. Pietroiusti, A., Magrini, A. & Campagnolo, L. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials. Toxicol. Appl. Pharma. 299, 90–95 (2016).
14. Hajipour, M. J. et al. Antibacterial properties of nanoparticles. Trends Biotechnol. 30, 499–511 (2012).
15. Gaillet, S. & Rouanet, J. M. Silver nanoparticles: their potential toxic effects after oral exposure and underlying mechanisms–a review. Food Chem. Toxicol. 77, 58–63 (2015).
16. Pulit-Prociak, J., Stoklosa, K. & Banach, M. Nanosilver products and toxicity. Environ. Chem. Lett. 13, 59–68 (2015).
17. Echegoyen, Y. & Nerin, C. Nanoparticle release from nano-silver antimicrobial food containers. Food Chem. Toxicol. 62, 16–22 (2013).
18. Pugliara., A. et al. Assessing bio-available silver released from silver nano-particles embedded in silica layers using the green algae Chlamydomonas reinhardtii as bio-sensors. Sci. Total Environ. 565, 8630871 (2016).
19. Mackevica, A., Olsson, M. E. & Hansen, S. F. Silver nanoparticle release from commercially available plastic food containers into food simulants. J. Nanopart. Res. 18, 1–11 (2016).
20. Loza, K., Sengstock, C., Chernousova, S., Koller, M. & Epple, M. The predominant species of ionic silver in biological media is colloidally dispersed nanoparticulate silver chloride. RSC Adv. 4, 35290–35297 (2014).
21. Cha, K. et al. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotech. Lett. 30, 1893–1899 (2008).
22. Kim, Y. S. et al. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 7, 20 (2010).
23. Shahare, B. & Yashpal, M. Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice. Toxicol. Mech. Methods 23, 161–167 (2013).
24. Jeong, G. N. et al. Histochemical study of intestinal mucins after administration of silver nanoparticles in Sprague-Dawley rats. Arch. Toxicol. 84, 63–69 (2010).
25. Hendrickson, O. D. et al. Toxicity of nanosilver in intragastric studies: Biodis-tribution and metabolic effects. Toxicol. Lett. 241, 184–192 (2016).
26. Kim, Y. S. et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20, 575–583 (2008).
27. Park, E. J. et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 30, 162–168 (2010).
28. Garcia, T. et al. Oral subchronic exposure to silver nanoparticles in rats. Food Chem. Toxicol. 7, 20 (2010).
29. Loeschner, K. et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fiber Toxicol. 8, 18 (2011).
30. Chen, N. et al. Toxicological effects of Caco-2 cells following short-term and long-term exposure to Ag nanoparticles. Int. J. Mol. Sci. 17, 974 (2016).
31. Georgantzopoulou, A. et al. Effects of silver nanoparticles and ions on a co-culture model for the gastrointestinal epithelium. Part. Fiber Toxicol. 13, 9 (2016).
32. Kim, T. H. et al. Size-dependent cellular toxicity of silver nanoparticles. J. Biomed. Mat. Res. A 100A, 1033–1043 (2012).
33. Sharma, V. K., Siskova, K. M., Zboril, R. & Gardea-Torresdey, J. L. Organic-coated silver nanoparticles in biological and environmental conditions: fate, stability and toxicity. Adv. Coll. Int. Sci. 204, 15–34 (2014).
34. Williams, K. et al. Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats. Nanotoxicology 9, 279–289 (2015).
35. Lichtenstein, D. et al. Impact of food components during in vitro digestion of silver nanoparticles on cellular uptake and cytotoxicity in intestinal cells. Biol. Chem. 396, 1255–1264 (2015).
36. Wang, Y. L. et al. A combined toxicity study of zinc oxide nanoparticles and vitamin C in food additives. Nanoscale 6, 15333–15342 (2014).
37. Sirelkhatim, A. et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano Micro Lett. 7, 219–242 (2015).
38. EFSA. Safety assessment of the substance zinc oxide, nanoparticles, for use in food contact materials. EFSDA J. 14, 4408: 4401–4408 (2016).
39. Bumbudsanpharoke, N. & Ko, S. Nano-food packaging: an overview of market, migration research, and safety regulations. J. Food Sci. 80, R910–R923 (2015).
40. Vandebriel, R. J. & De Jong, W. H. A review of mammalian toxicity of ZnO nanoparticles. Nanotech. Sci. Appl. 5, Article 61 (2012).
41. Pasupuleti, S. et al. Toxicity of zinc oxide nanoparticles through oral route. Toxicol. Ind. Health 28, 675–686 (2012).
42. Wang, B. et al. Acute toxicological impact of nano-and submicro-scaled zinc oxide powder on healthy adult mice. J. Nanopart. Res. 10, 263–276 (2008).
43. Wang, H., Du, L.-J., Song, Z.-M. & Chen, X.-X. Progress in the characterization and safety evaluation of engineered inorganic nanomaterials in food. Nanomedicine 8, 2007–2025 (2013).
44. Esmaeillou, M., Moharamnejad, M., Hsankhani, R., Tehrani, A. A. & Maadi, H. Toxicity of ZnO nanoparticles in healthy adult mice. Env. Toxicol. Pharmacol. 35, 67–71 (2013).
45. Kang, T. S. et al. Cytotoxicity of zinc oxide nanoparticles and silver nanoparticles in human epithelial colorectal adenocarcinoma cells. Food Sci. Technol. 60, 1143–1148 (2015).
46. Bacchetta, R. et al. Evidence and uptake routes for zinc oxide nanoparticles through the gastrointestinal barrier in Xenopus laevis. Nanotoxicology 8, 728–744 (2014).
47. Raspopov, R. V., Trushina, E. N., Gmoshinsky, I. V. & Khotimchenko, S. A. Bioa-vailability of nanoparticles of ferric oxide when used in nutrition. Experimental results in rats. Vopr. Pitan. 80, 25–30 (2011).
48. Zimmermann, M. B. & Hilty, F. M. Nanocompounds of iron and zinc: their potential in nutrition. Nanoscale 3, 2390–2398 (2011).
49. Wu, H. H., Yin, J. J., Wamer, W. G., Zeng, M. Y. & Lo, Y. M. Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides. J. Food Drug. Anal. 22, 86–94 (2014).
50. Hilty, F. M. et al. Iron from nanocompounds containing iron and zinc is highly bioavailable in rats without tissue accumulation. Nat. Nanotech. 5, 374–380 (2010).
51. WHO in Safety Evaluation of Certain Food Additives and Contaminants Vol. 44, 1–2 (World Health Organization, 2000).
52. Fulgoni, V. L., Keast, D. R., Bailey, R. L. & Dwyer, J. Foods, fortificants, and sup-plements: where do Americans get their nutrients? J. Nutr. 141, 1847–1854 (2011).
53. Patil, U. S. et al. in vitro/in vivo toxicity evaluation and quantification of iron oxide nanoparticles. Int. J. Mol. Sci. 16, 24417–24450 (2015).
54. Yun, J. W. et al. Comparative toxicity of silicon dioxide, silver and iron oxide nanoparticles after repeated oral administration to rats. J. Appl. Toxicol. 35, 681–693 (2015).
55. Weir, A., Westerhoff, P., Fabricius, L., Hristovski, K. & von Goetz, N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 46, 2242–2250 (2012).
56. Jovanović, B. Critical review of public health regulations of titanium dioxide, a human food additive. Integr. Environ. Assess. Manag. 11, 10–20 (2015).
57. Warheit, D. B., Brown, S. C. & Donner, E. M. Acute and subchronic oral toxicity studies in rats with nanoscale and pigment grade titanium dioxide particles. Food Chem. Toxicol. 84, 208–224 (2015).
58. Weir, A., Westerhoff, P., Fabricius, L., Hristovski, K. & von Goetz, N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 46, 2242–2250 (2012).
59. Chen, X. X. et al. Characterization and preliminary toxicity assay of nano-titanium dioxide additive in sugar-coated chewing gum. Small 9, 1765–1774 (2013).
60. Yang, Y. et al. Characterization of food-grade titanium dioxide: the presence of nanosized particles. Environ. Sci. Technol. 48, 6391–6400 (2014).
61. Wang, J. et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 168, 176–185 (2007).
62. Duan, Y. et al. Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials 31, 894–899 (2010).
63. Nogueira, C. M. et al. Titanium dioxide induced inflammation in the small intestine. World J. Gastroenterol. 18, 4729–4735 (2012).
64. Bu, Q. et al. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 21, 125105 (2010).
65. Cho, W.-S. et al. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part. Fibre Toxicol. 10, Article 1 (2013).
66. Wang, Y. et al. Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles. Small 9, 1742–1752 (2013).
67. Tada-Oikawa, S. et al. Titanium dioxide particle type and concentration influence the inflammatory response in Caco-2 cells. Int. J. Mol. Sci. 17, 576 (2016). Article.
68. Song, Z. M. et al. Biological effect of food additive titanium dioxide nano-particles on intestine: an in vitro study. J. Appl. Toxicol. 35, 1169–1178 (2015).
69. Brun, E. et al. Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia. Part. Fiber Toxicol. 11, 13 (2014).
70. Chalew, T. E. A. & Schwab, K. J. Toxicity of commercially available engineered nanoparticles to Caco-2 and SW480 human intestinal epithelial cells. Cell Biol. Toxicol. 29, 101–116 (2013).
71. Gerloff, K., Albrecht, C., Boots, A. W., Forster, I. & Schins, R. P. F. Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco-2 cells. Nanotoxicology 3, 355–364 (2009).
72. Dorier, M. et al. Impact of anatase and rutile titanium dioxide nanoparticles on uptake carriers and efflux pumps in Caco-2 gut epithelial cells. Nanoscale 7, 7352–7360 (2015).
73. Kruger, K., Cossais, F., Neve, H. & Klempt, M. Titanium dioxide nanoparticles activate IL8-related inflammatory pathways in human colonic epithelial Caco-2 cells. J. Nanopart. Res. 16, Article 2402 (2014).
74. Dorier, M. et al. Impact of anatase and rutile titanium dioxide nanoparticles on uptake carriers and efflux pumps in Caco-2 gut epithelial cells. Nanoscale 7, 7352–7360 (2015).
75. Gerloff, K. et al. Distinctive toxicity of TiO2 rutile/anatase mixed phase nano-particles on Caco-2 cells. Chem. Res. Toxicol. 25, 646–655 (2012).
76. Monopoli, M. P. et al. Physical−chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 133, 2525–2534 (2011).
77. Lesniak, A. et al. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J. Am. Chem. Soc. 135, 1438–1444 (2013).
78. Dekkers, S. et al. Presence and risks of nanosilica in food products. Nanotox-icology 5, 393–405 (2011).
79. Peters, R. et al. Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive. ACS Nano 6, 2441–2451 (2012).
80. Yang, Y. et al. Survey of food-grade silica dioxide nanomaterial occurrence, characterization, human gut impacts and fate across its lifecycle. Sci. Total Environ. 565, 902–912 (2016).
81. Athinarayanan, J., Periasamy, V. S., Alsaif, M. A., Al-Warthan, A. A. & Alshatwi, A. A. Presence of nanosilica (E551) in commercial food products: TNF-mediated oxi-dative stress and altered cell cycle progression in human lung fibroblast cells. Cell. Biol. Toxicol. 30, 89–100 (2014).
82. van Kesteren, P. C. E. et al. Novel insights into the risk assessment of the nanomaterial synthetic amorphous silica, additive E551, in food. Nanotoxicology 9, 442–452 (2015).
83. So, S. J., Jang, I. S. & Han, C. S. Effect of micro/nano silica particle feeding for mice. J. Nanosci. Nanotech. 8, 5367–5371 (2008).
84. McClements, D. J. Edible lipid nanoparticles: digestion, absorption, and potential toxicity. Prog. Lipid Res. 52, 409–423 (2013).
85. Piorkowski, D. T. & McClements, D. J. Beverage emulsions: recent developments in formulation, production, and applications. Food Hydrocoll. 42, 5–41 (2014).
86. Livney, Y. D. Nanostructured delivery systems in food: latest developments and potential future directions. Curr. Opin. Food Sci. 3, 125–135 (2015).
87. McClements, D. J. Reduced-fat foods: the complex science of developing diet-based strategies for tackling overweight and obesity. Adv. Nutr. 6, 338S–352S (2015).
88. Shin, G. H., Kim, J. T. & Park, H. J. Recent developments in nanoformulations of lipophilic functional foods. Trends Food Sci. Tech. 46, 144–157 (2015).
89. Yao, M., McClements, D. J. & Xiao, H. Improving oral bioavailability of nutra-ceuticals by engineered nanoparticle-based delivery systems. Curr. Opin. Food Sci. 2, 14–19 (2015).
90. McClements, D. J. & Rao, J. Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit. Rev. Food Sci. Nutr. 51, 285–330 (2011).
91. McClements, D. J. & Xiao, H. Potential biological fate of ingested nanoemulsions: influence of particle characteristics. Food Funct. 3, 202–220 (2012).
92. McClements, D. J. Design of nano-laminated coatings to control bioavailability of lipophilic food components. J. Food Sci. 75, R30–R42 (2010).
93. Oftedal, O. T. The evolution of milk secretion and its ancient origins. Animal 6, 355–368 (2012).
94. Rajendran, S., Udenigwe, C. C. & Yada, R. Y. Nanochemistry of protein-based delivery agents. Front. Chem. 4, 31 (2016).
95. Davidov-Pardo, G., Joye, I. J. & McClements, D. J. Food-grade protein-based nanoparticles and microparticles for bioactive delivery: fabrication, character-ization, and utilization. Adv. Protein Chem. Struct. Biol. 98, 293–325 (2015).
96. Myrick, J. M., Vendra, V. K. & Krishnan, S. Self-assembled polysaccharide nanostructures for controlled-release applications. Nanotech. Rev. 3, 319–346 (2014).
97. Joye, I. J., Davidov-Pardo, G. & McClements, D. J. Nanotechnology for increased micronutrient bioavailability. Trends Food Sci. Tech. 40, 168–182 (2014).
98. Le Corre, D., Bras, J. & Dufresne, A. Starch nanoparticles: a review. Biomacro-molecules 11, 1139–1153 (2010).
99. Jones, O. G. & McClements, D. J. Functional biopolymer particles: design, fab-rication, and applications. Comp. Rev. Food Sci. Food Saf. 9, 374–397 (2010).
100. McClements, D. J. Advances in fabrication of emulsions with enhanced functionality using structural design principles. Curr. Opin. Colloid Int. Sci. 17, 235–245 (2012).
101. McClements, J. & McClements, D. J. Standardization of nanoparticle character-ization: methods for testing properties, stability, and functionality of edible nanoparticles. Crit. Rev. Food Sci. Nutr. 56, 1334–1362 (2016).
102. Wang, H., Du, L. J., Song, Z. M. & Chen, X. X. Progress in the characterization and safety evaluation of engineered inorganic nanomaterials in food. Nanomedicine 8, 2007–2025 (2013).
103. Singh, G., Stephan, C., Westerhoff, P., Carlander, D. & Duncan, T. V. Measurement methods to detect, characterize, and quantify engineered nanomaterials in foods. Comp. Rev. Food Sci. Food Saf. 13, 693–704 (2014).
104. Pradeep, T. & Anshup Noble metal nanoparticles for water purification: a critical review. Thin Solid Films. 517, 6441–6478 (2009).
105. Ensign, L. M., Cone, R. & Hanes, J. Oral drug delivery with polymeric nano-particles: the gastrointestinal mucus barriers. Adv. Drug Deliv. Rev. 64, 557–570 (2012).
106. Frohlich, E. & Roblegg, E. Models for oral uptake of nanoparticles in consumer products. Toxicology 291, 10–17 (2012).
107. Magnuson, B. A., Jonaitis, T. S. & Card, J. W. A brief review of the occurrence, use, and safety of food-related nanomaterials. J. Food Sci. 76, R126–R133 (2011).
108. Powell, J. J., Faria, N., Thomas-McKay, E. & Pele, L. C. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J. Autoimmun. 34, J226–J233 (2010).
109. McClements, D. J. et al. The role of the food matrix and gastrointestinal tract in the assessment ofbiological properties of ingested engineered nanomaterials (iENMs): state of the science and knowledge gaps. NanoImpact 3-4, 47–57 (2016).
110. Saptarshi, S. R., Duschl, A. & Lopata, A. L. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J. Nanobiotech. 11, Article 1 (2013).
111. Monopoli, M. P., Åberg, C., Salvati, A. & Dawson, K. A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechn. 7, 779–786 (2012).
112. Cao, X. et al. Characterization of the interactions between titanium dioxide nanoparticles and polymethoxyflavones using surface-enhanced Raman spec-troscopy. J. Agric. Food Chem. 64, 9436–9441 (2016).
113. Blijdenstein, T. B. J., van der Linden, E., van Vliet, T. & van Aken, G. A. Scaling behavior of delayed demixing, rheology, and microstructure of emulsions flocculated by depletion and bridging. Langmuir 20, 11321–11328 (2004).
114. de Hoog, E. H. A., Prinz, J. F., Huntjens, L., Dresselhuis, D. M. & van Aken, G. A. Lubrication of oral surfaces by food emulsions: the importance of surface characteristics. J. Food Sci. 71, E337–E341 (2006).
115. Silletti, E., Vingerhoeds, M. H., Norde, W. & Van Aken, G. A. The role of electro-statics in saliva-induced emulsion flocculation. Food Hydrocoll. 21, 596–606 (2007).
116. Vingerhoeds, M. H., Blijdenstein, T. B. J., Zoet, F. D. & van Aken, G. A. Emulsion flocculation induced by saliva and mucin. Food Hydrocoll. 19, 915–922 (2005).
117. Mahmoudi, M. et al. Protein−nanoparticle interactions: opportunities and chal-lenges. Chem. Rev. 111, 5610–5637 (2011).
118. Giri, K. et al. Understanding protein–nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug. Chem. 25, 1078–1090 (2014).
119. Lacerda, S. H. D. P. et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4, 365–379 (2009).
120. Dobrovolskaia, M. A. et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed. Nanotechnol. Biol. Med. 5, 106–117 (2009).
121. Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A. & McNeil, S. E. Nanoparticle interaction with plasma proteins as it relates to particle biodis-tribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61, 428–437 (2009).
122. Das, P. et al. Interaction between a broad-spectrum antibiotic and silver nano-particles in a human gut ecosystem. J. Nanomed. Nanotechnol. 7, 1–7 (2016).
123. Di Silvio, D., Rigby, N., Bajka, B., Mackie, A. & Bombelli, F. B. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake. Int. J. Biochem. Cell Biol. 75, 212–222 (2016).
124. Lichtenstein, D. et al. Impact of food components during in vitro digestion of silver nanoparticles on cellular uptake and cytotoxicity in intestinal cells. Biol. Chem. 396, 1255–1264 (2015).
125. Orfi, E. & Szebeni, J. The immune system of the gut and potential adverse effects of oral nanocarriers on its function. Adv. Drug Deliv. Rev. 106, 402–409 (2016).
126. Choi, J. et al. Toxicity of zinc oxide nanoparticles in rats treated by two different routes: single intravenous injection and single oral administration. J. Toxicol. Environ. Health A 78, 226–243 (2015).
127. Esmaeillou, M., Moharamnejad, M., Hsankhani, R., Tehrani, A. A. & Maadi, H. Toxicity of ZnO nanoparticles in healthy adult mice. Environ. Toxicol. Pharmacol. 35, 67–71 (2013).
128. Salvia-Trujillo, L., Qian, C., Martin-Belloso, O. & McClements, D. J. Influence of particle size on lipid digestion and beta-carotene bioaccessibility in emulsions and nanoemulsions. Food Chem. 141, 1472–1480 (2013).
129. Shaikh, J., Ankola, D. D., Beniwal, V., Singh, D. & Kumar, M. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37, 223–230 (2009).
130. Sun, J. et al. Effect of particle size on solubility, dissolution rate, and oral bioa-vailability: evaluation using coenzyme Q(10) as naked nanocrystals. Int. J. Nanomed. 7, 5733–5744 (2012).
131. Cho, H. T. et al. Droplet size and composition of nutraceutical nanoemulsions influences bioavailability of long chain fatty acids and Coenzyme Q10. Food Chem. 156, 117–122 (2014).
132. Walker, R., Decker, E. A. & McClements, D. J. Development of food-grade nanoemulsions and emulsions for delivery of omega-3 fatty acids: opportunities and obstacles in the food industry. Food Funct. 6, 42–55 (2015).
133. Katouzian, I. & Jafari, S. M. Nano-encapsulation as a promising approach for targeted delivery and controlled release of vitamins. Trends Food Sci. Technol. 53, 34–48 (2016).
134. Miller, E. R. et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37–46 (2005).
135. Salvia-Trujillo, L., Martin-Belloso, O. & McClements, D. J. Excipient nanoemulsions for improving oral bioavailability of bioactives. Nanomaterials 6, 1–16 (2016).
136. Consortium, H. M. P. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–221 (2012).
137. Pflughoeft, K. J. & Versalovic, J. Human microbiome in health and disease. Ann. Rev. Pathol. 7, 99–122 (2012).